A 6-month, randomized, double-blind, parallel-group, controlled, multi-center study to evaluate the incidence of gastric ulcers with PN 400 (esomeprazole/Naproxen) versus diclofenac/misoprostol in subjects who are at high risk for developing NSAID [non steroidal anti-inflammatory drugs]-associated ulcers.

Trial Profile

A 6-month, randomized, double-blind, parallel-group, controlled, multi-center study to evaluate the incidence of gastric ulcers with PN 400 (esomeprazole/Naproxen) versus diclofenac/misoprostol in subjects who are at high risk for developing NSAID [non steroidal anti-inflammatory drugs]-associated ulcers.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 27 Aug 2010

At a glance

  • Drugs Diclofenac/misoprostol; Esomeprazole/naproxen
  • Indications Ankylosing spondylitis; NSAID-induced ulcer; Osteoarthritis; Rheumatoid arthritis
  • Focus Adverse reactions
  • Sponsors POZEN
  • Most Recent Events

    • 28 May 2008 Status change from recruiting to discontinued, according to clinicaltrials.gov.
    • 31 Jan 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top